Find a Clinical Trial
Filter
PATH-2: PLS240
Hemodialysis access, Thyroid diseases
All genders
18-80
Recruiting now
Division of Nephrology
DEFENDO Long-Term Follow-Up Study
Neurotrophic keratitis
All genders
18+
Recruiting now
Department of Ophthalmology
MLS-101-206
Chronic kidney disease
All genders
18-100
Recruiting now
Department of Medicine, Division of Nephrology
SEER-2
Neurotrophic keratitis
All genders
18+
Recruiting now
Department of Ophthalmology
POETYK SjS-1
Sjogren's syndrome
All genders
18+
Recruiting now
Department of Ophthalmology
R3R
Chronic kidney disease
All genders
12+
Recruiting now
Department of Medicine, Division of Nephrology
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
BALATON
Macular degeneration
All genders
18+
Recruiting now
Department of Ophthalmology
Belvedere
Macular degeneration
All genders
50+
Recruiting now
Department of Ophthalmology
Assist
Chronic kidney disease
All genders
18+
Recruiting now
Department of Medicine, Division of Nephrology